Wealth Quarterback’s NeoGenomics NEO Stock Holding History

Wealth Quarterback’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-400	Closed	-$11K	–	521
2020 Q1	$11K	Buy	400 +105	+36%	+$3.15K	0.01%	450
2019 Q4	$8.63K	Buy	+295	New	+$7.03K	0.01%	559

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Quarterback's NEO Position: Q2 2020 in Review

Wealth Quarterback sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 400 shares — an estimated $11K sold.

Wealth Quarterback first reported a position in NEO in Q4 2019 and held it in 2 quarters. The position peaked at $11K in Q1 2020. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

Wealth Quarterback reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
Wealth Quarterback sold 400 NeoGenomics shares in Q2 2020, an estimated $11K.
Wealth Quarterback first reported a position in NeoGenomics in Q4 2019 and held it in 2 quarters.
Wealth Quarterback's NeoGenomics position peaked at $11K in Q1 2020.
285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on Wealth Quarterback's 13F filing for Q2 2020, filed 17 Aug 2020.